BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 27443285)

  • 1. SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course.
    Dezorella N; Katz BZ; Shapiro M; Polliack A; Perry C; Herishanu Y
    Haematologica; 2016 Dec; 101(12):1553-1562. PubMed ID: 27443285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia.
    Feng G; Wang X
    Leuk Lymphoma; 2014 Dec; 55(12):2699-705. PubMed ID: 24547708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
    Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
    Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between ZAP-70, phospho-ZAP-70, and phospho-Syk expression in leukemic cells from patients with CLL.
    Kaplan D; Meyerson HJ; Li X; Drasny C; Liu F; Costaldi M; Barr P; Lazarus HM
    Cytometry B Clin Cytom; 2010 Mar; 78(2):115-22. PubMed ID: 20014315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKCα subversion induces up-regulation of PKCβII expression in B lymphocytes.
    Nakagawa R; Vukovic M; Tarafdar A; Cosimo E; Dunn K; McCaig AM; Holroyd A; McClanahan F; Ramsay AG; Gribben JG; Michie AM
    Haematologica; 2015 Apr; 100(4):499-510. PubMed ID: 25616575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
    Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
    Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells.
    Efremov DG; Gobessi S; Longo PG
    Autoimmun Rev; 2007 Dec; 7(2):102-8. PubMed ID: 18035318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.
    Cutrona G; Colombo M; Matis S; Fabbi M; Spriano M; Callea V; Vigna E; Gentile M; Zupo S; Chiorazzi N; Morabito F; Ferrarini M
    Haematologica; 2008 Mar; 93(3):413-22. PubMed ID: 18287138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells.
    Gobessi S; Laurenti L; Longo PG; Sica S; Leone G; Efremov DG
    Blood; 2007 Mar; 109(5):2032-9. PubMed ID: 17038529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies.
    Cesano A; Perbellini O; Evensen E; Chu CC; Cioffi F; Ptacek J; Damle RN; Chignola R; Cordeiro J; Yan XJ; Hawtin RE; Nichele I; Ware JR; Cavallini C; Lovato O; Zanotti R; Rai KR; Chiorazzi N; Pizzolo G; Scupoli MT
    Haematologica; 2013 Apr; 98(4):626-34. PubMed ID: 23144194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ZAP-70/Syk mRNA levels with immunoglobulin heavy-chain gene mutation status and disease progression in chronic lymphocytic leukemia.
    Laurenti L; Petlickovski A; Rumi C; Gobessi S; Piccioni P; Tarnani M; Puggioni P; Marietti S; Sica S; Leone G; Efremov DG
    Haematologica; 2005 Nov; 90(11):1533-40. PubMed ID: 16266901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia.
    Paiva C; Rowland TA; Sreekantham B; Godbersen C; Best SR; Kaur P; Loriaux MM; Spurgeon SEF; Danilova OV; Danilov AV
    Haematologica; 2017 Nov; 102(11):1890-1900. PubMed ID: 28838991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
    Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
    Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia.
    Chen L; Apgar J; Huynh L; Dicker F; Giago-McGahan T; Rassenti L; Weiss A; Kipps TJ
    Blood; 2005 Mar; 105(5):2036-41. PubMed ID: 15514014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression levels of Lyn, Syk, PLCγ2 and ERK in patients with chronic lymphocytic leukemia, and higher levels of Lyn are associated with a shorter treatment-free survival.
    Wang YH; Fan L; Wang L; Zhang R; Zou ZJ; Fang C; Zhang LN; Li JY; Xu W
    Leuk Lymphoma; 2013 Jun; 54(6):1165-70. PubMed ID: 23039362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of
    Cavallini C; Visco C; Putta S; Rossi D; Mimiola E; Purvis N; Lovato O; Perbellini O; Falisi E; Facco M; Trentin L; Romanelli MG; Semenzato G; Ambrosetti A; Gaidano G; Pizzolo G; Cesano A; Scupoli MT
    Haematologica; 2017 Apr; 102(4):e144-e147. PubMed ID: 27927769
    [No Abstract]   [Full Text] [Related]  

  • 17. The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia.
    Le Roy C; Deglesne PA; Chevallier N; Beitar T; Eclache V; Quettier M; Boubaya M; Letestu R; Lévy V; Ajchenbaum-Cymbalista F; Varin-Blank N
    Blood; 2012 Jul; 120(2):356-65. PubMed ID: 22613791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cbl enforces an SLP76-dependent signaling pathway for T cell differentiation.
    Chiang YJ; Jordan MS; Horai R; Schwartzberg PL; Koretzky GA; Hodes RJ
    J Biol Chem; 2009 Feb; 284(7):4429-38. PubMed ID: 19074136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
    Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ
    N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.